DH Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
55.2M
-1.3%
55.9M
-9.1%
61.5M
+2.5%
60.0M
-1.2%
60.8M
Cost of Revenue
14.7M
+2.6%
14.3M
-2.4%
14.6M
+4.1%
14.1M
-0.6%
14.1M
Gross Profit
40.5M
-2.7%
41.6M
-11.2%
46.9M
+2.0%
46.0M
-1.3%
46.6M
Operating Expenses
47.3M
-80.5%
242.9M
+230.4%
73.5M
+34.5%
54.7M
+7.7%
50.8M
R&D
6.8M
+4.0%
6.5M
-34.7%
10.0M
+31.8%
7.6M
-5.2%
8.0M
SG&A
30.0M
-5.4%
31.7M
-8.1%
34.5M
+5.2%
32.7M
-1.2%
33.1M
Operating Income
-6748000
+96.6%
-201290000
-656.0%
-26627000
-206.5%
-8688000
-108.3%
-4170000
EBITDA
12.8M
+5.0%
12.2M
+9.3%
11.1M
-24.2%
14.7M
-1.0%
14.8M
Net Income
-7452000
+96.1%
-192354000
-1021.8%
-17147000
+3.6%
-17792000
-92.0%
-9265000
EPS (Basic)
$-0.05
+96.2%
$-1.32
-1366.7%
$-0.09
+35.7%
$-0.14
-100.0%
$-0.07
EPS (Diluted)
$-0.05
+96.2%
$-1.32
-1366.7%
$-0.09
+35.7%
$-0.14
-100.0%
$-0.07
Shares (Diluted)
105.8M
+1.1%
104.7M
+1.4%
103.2M
-0.5%
103.8M
-2.8%
106.8M
Definitive Healthcare (DH) โ€” Financials